MAPT and Alzheimer disease: The administration of antioxidants (800 IU/d of vitamin E + 500 mg/d vitamin C + 900 mg/d α-lipoic acid) for 16 weeks did not change AD biomarkers (CSF Aβ/tau), but it showed a reduction in F2-isoprostane levels related to oxidative stress in the brain [131].